Orthocell (ASX: OCC) Lines Up UK Distributor for Remplir Ahead of Approval- Is Now the Time to Buy?
Orthocell Moves Closer to UK Growth Orthocell (ASX: OCC) just made a move that not every small-cap medtech company would…
Westgold Resources Greenlights A$145m Higginsville Expansion: Is WGX a Buy as Gold Stays Strong?
Westgold Expansion Boosts Growth Case for WGX Westgold Resources (ASX: WGX) rose just 3.2% to A$6.45 on Tuesday after its…
ASX Rebounds on Trump’s Iran Comments: Three Reasons Not to Buy This Rally Yet
ASX Bounce Looks Fragile Despite Trump’s Iran Remarks The ASX 200 climbed 1.1% to close at 8,692.6 on Tuesday after…
Oil Dumps as Trump Signals the War Could End Soon
Oil Pulls Back Hard, But Hormuz Risk Still Sets the Floor The core reason oil prices plunged was that President…
Fortuna Metals (ASX:FUN) Mkanda Delivers High Grade Rutile Zones, 485 Holes Still to Come
First Drilling Hits Kasiya Style Rutile Fortuna Metals is a small ASX-listed miner with exposure to the Mkanda and Kampini…
Telix (ASX:TLX) Green Light to Move Into the Pivotal Phase 3 Study
TLX591-Tx Hits Safety Goals, US Enrollment Now in Sight Telix is developing a new type of cancer treatment for advanced…
What does the 2026 health insurance premium rise mean for ASX health insurance stocks?
The 2026 health insurance premium rise is in, and it is 4.41%. It made headlines because it is ahead of…
Revolver Resources (ASX:RRR): Dianne was once Australia’s highest-grade copper mine, now it is in Revolver’s hands
Revolver Resources (ASX:RRR) can boast in a way few other ASX resources juniors can, in having a project that was…
Beach Energy Jumps 5% on A$250m Moomba FID: Is BPT a Buy or a Value Trap?
Beach Energy Rises on Moomba Deal- Is It a Buy Now? Beach Energy (ASX: BPT) spiked as much as 5%…
Dyno Nobel (ASX: DNL) Falls Nearly 10% After Selling Phosphate Hill for $1 – Is the Selloff a Buying Opportunity?
Dyno Nobel Sinks After Phosphate Hill Sale Dyno Nobel (ASX: DNL) fell 9.73% on Monday after confirming the sale of…
Pro Medicus (ASX: PME) Falls Despite A$40m in US Renewals: Is This a Buying Opportunity?
Pro Medicus Dips Despite Strong Renewals Pro Medicus (ASX: PME) slipped around 1% on Monday despite announcing approximately A$40m in…
ServiceNow (NYSE:NOW): Is this American SaaS company showing its peers how to overcome AI fears?
ServiceNow (NYSE:NOW) caught our eye at Stocks Down Under because we noticed shares had rebounded in the past couple of…
ASX Plunges A$95 Billion on Oil Shock: 5 Stocks to Buy Right Now
ASX Stocks to Buy After the Oil Shock The ASX 200 fell as much as 4.4% intraday before closing 2.85%…
Anthropic Draws a Line With the Pentagon
The AI-First Military Agenda with Anthropic The Pentagon is moving aggressively to bring cutting-edge commercial AI into defence work. A…